Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$3.43 - $3.96 $1.15 Million - $1.33 Million
-335,365 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$2.2 - $3.94 $737,803 - $1.32 Million
335,365 New
335,365 $1.3 Million

Others Institutions Holding THTX

# of Institutions
1
Shares Held
29.2K
Call Options Held
0
Put Options Held
0

About Theratechnologies Inc.


  • Ticker THTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 95,141,600
  • Market Cap $116M
  • Description
  • Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...
More about THTX
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.